Tsis ntev los no, Ningbo Meinuohua Pharmaceutical Co., Ltd. (tom qab no hu ua "Lub Tuam Txhab") tau txais daim ntawv pov thawj ntawm Kev Tsim Nyog rau Monographs ntawm European Pharmacopoeia (CEP) tawm los ntawm European Directorate rau Cov Tshuaj Zoo & Kev Noj Qab Haus Huv (EDQM) rau nws cov Perindopril Tertyl {2}Butacetyl Cov khoom xyaw). Lub Tuam Txhab ntawm no tshaj tawm cov ntaub ntawv sau npe cuam tshuam raws li hauv qab no:
I. Cov Ntaub Ntawv Tseem Ceeb ntawm Cov Tshuaj
Tshuaj Lub Npe: Perindopril Tert-butylamine / Perindopril Erbumine (Cov Khoom Siv Tshuaj Siv Hluav Taws Xob) Daim Ntawv Pov Thawj Hom: European CEP CertificateCertificate Number: CEP 2022-207-Rev 00Company Name: Ningbo Meinuohua Pharmace, Ltd. 1, Ningbo R&D Park, No. 999 Yangfan Road, Ningbo High-tech ZoneIssuing Authority: European Directorate for the Quality of Medicines & HealthCare (EDQM)
II. Indications thiab Pharmacological teebmeem
Tshuaj Indications: Hypertension thiab congestive plawv tsis ua hauj lwm.
Pharmacological Effects thiab Mechanism of Action: Perindopril yog angiotensin -hloov enzyme inhibitor (ACEI). Angiotensin- hloov enzyme tuaj yeem hloov angiotensin Ⅰ mus rau angiotensin Ⅱ, uas muaj cov nyhuv vasoconstrictive. Tsis tas li ntawd, cov enzyme no tuaj yeem ua rau muaj kev tso tawm ntawm aldosterone los ntawm lub raum cortex thiab degrade bradykinin (ib vasodilator) rau hauv heptapeptides tsis ua haujlwm. Perindopril exerts nws cov teebmeem los ntawm nws cov nquag metabolite, perindoprilat.
